tiprankstipranks
Artiva Biotherapeutics, Inc. (ARTV)
NASDAQ:ARTV
US Market
ARTV
Artiva Biotherapeutics, Inc.
RESEARCH TOOLSreports

Artiva Biotherapeutics, Inc. (ARTV) Financial Statements

454 Followers

Artiva Biotherapeutics, Inc. Financial Overview

Artiva Biotherapeutics, Inc.'s market cap is currently $164.86M. The company's EPS TTM is $-0.85; its P/E ratio is -1.26; Artiva Biotherapeutics, Inc. is scheduled to report earnings on March 10, 2026, and the estimated EPS forecast is $-0.87. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue$ 0.00$ 251.00K$ 33.49M$ 4.93M$ 2.00M
Gross Profit$ -2.60M$ 251.00K$ 33.49M$ 4.93M$ 2.00M
Operating Income$ -90.61M$ -67.28M$ -30.67M$ -59.83M$ -53.27M
EBITDA$ -88.01M$ -64.85M$ -28.41M$ -58.67M$ -71.58M
Net Income$ -83.86M$ -58.49M$ -27.70M$ -58.39M$ -71.83M
Balance Sheet
Cash & Short-Term Investments$ 108.01M$ 185.43M$ 76.97M$ 102.53M$ 160.92M
Total Assets$ 130.94M$ 209.58M$ 105.11M$ 133.05M$ 169.93M
Total Debt$ 10.94M$ 14.35M$ 16.91M$ 19.45M$ 1.74M
Net Debt$ -15.76M$ -25.88M$ -36.59M$ -83.08M$ -159.18M
Total Liabilities$ 20.97M$ 22.94M$ 267.13M$ 273.75M$ 258.78M
Stockholders' Equity$ 109.97M$ 186.64M$ -162.01M$ -140.70M$ -88.86M
Cash Flow
Free Cash Flow$ -79.34M$ -55.67M$ -50.69M$ -57.13M$ -17.03M
Operating Cash Flow$ -76.75M$ -55.03M$ -47.43M$ -50.83M$ -15.30M
Investing Cash Flow$ 63.41M$ -120.46M$ -25.98M$ -6.30M$ -1.72M
Financing Cash Flow$ 9.00K$ 162.23M$ 24.39M$ -1.26M$ 152.75M
Currency in USD

Artiva Biotherapeutics, Inc. Earnings and Revenue History

Income Statement >

Artiva Biotherapeutics, Inc. Debt to Assets

Balance Sheet >

Artiva Biotherapeutics, Inc. Cash Flow

Cash Flow >

Artiva Biotherapeutics, Inc. Forecast EPS vs Actual EPS

Earnings >